Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Sernova Corp > big events are approaching
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(239)
•••
Post by Charly50on Apr 12, 2022 11:46am
157 Views
Post# 34597140

big events are approaching

big events are approaching
 Bio, stop whining. Treat yourself to a break and book a sailing boat trip with Metalle. dr Anke Schulthe from Bayer, formerly Sanofi, will give you mineral water. Frank and PT drink champagne and toast to big events: Upcoming events Event - April 20, 2022 Cell & Gene Meeting on the Med Event - April 28, 2022 Sernova Virtual Annual General Meeting (AGM) Event - May 02, 2022 2022 Bloom Burton & Co Healthcare Investor Conference Event - May 17, 2022 Roth Canada Corporate Access Day Event - May 23, 2022 H.C. Wainwright Global Life Sciences Conference Event - May 24, 2022 Oppenheimer MedTech Summit Event - June 13, 2022 BIO International Convention Event - June 28, 2022 A Truist Securities Cell Therapy Symposium
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities